This post is important drugruner, your sayng that dcvax is going to come out on the market priced lower than keytruda or Car T yet will have better outcomes and less side effects...making it ultimatley cheaper to the health system. Currently Nwbo hands are tied because they cant promote or talk about the drug before approvoal. NWBO big pharma partner has most likely been offering larger dollars to take the time to hit milestones. Because we all know that big pharma is in no rush to announce this new breakthrough I believe the British health care system wants to take leadership role in the world providing new cutting edge therapies. And beyond that selling the treatment to people all over the world that trust the British medical regulatory system and will pay for it. Thus we had the liscence granted for Advent to export their cell treatment around the world. Britian will pay for gliobastoma patients for citizens and sell treatment to any other people that can afford it.
Market Data 
Markets 
